@article{4caf8fb6538845c6a8a82f3df4b56356,
title = "Innate Immune Regulation of Dermatitis",
keywords = "Allergic contact dermatitis (ACD), Atopic dermatitis (AD), Itch, Janus kinase (JAK), Mas-related G protein–coupled receptor (MRGPR), Mast cells, Urticaria",
author = "Damien Abreu and Kim, {Brian S.}",
note = "Funding Information: B.S. Kim has served as a consultant for AbbVie, ABRAX Japan, Almirall, AstraZeneca, Cara Therapeutics, Daewoong Pharmaceutical, Incyte, LEO Pharma, Lilly, Maruho, Menlo Therapeutics, OM Pharma, Pfizer, and Third Rock Ventures. He has also participated on the advisory board for Almirall, Boehringer Ingelheim, Cara Therapeutics, Kiniksa Pharmaceuticals, Menlo Therapeutics, Regeneron Pharmaceuticals, Sanofi Genzyme, and Trevi Therapeutics. He is stockholder of Locus Biosciences. All other authors declare that they have no relevant conflicts of interest.",
year = "2021",
month = aug,
doi = "10.1016/j.iac.2021.04.011",
language = "English",
volume = "41",
pages = "347--359",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
number = "3",
}